{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "identified-subcommittee",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import seaborn as sb\n",
    "import matplotlib.pyplot as plt\n",
    "# data = pd.read_csv(r'database_valid.csv', encoding = 'latin-1', sep = ';')\n",
    "data = pd.read_csv(\"https://covid-nma.com/dataviz/data/database_valid.csv\", sep = \";\",encoding='latin-1').drop(index = [0])\n",
    "\n",
    "df = pd.DataFrame(data)\n",
    "# print(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "pressed-maryland",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(      Unnamed: 0  Trial ID Trial registration number  \\\n",
       " 546        546.0     233.0    EUCTR2020-001270-29-GB   \n",
       " 597        597.0     254.0               NCT04332991   \n",
       " 662        662.0     278.0               NCT04343092   \n",
       " 1074      1074.0     449.0               NCT04345289   \n",
       " 1181      1181.0     495.0               NCT04358081   \n",
       " 1317      1317.0     553.0    EUCTR2020-001417-21-BE   \n",
       " 1323      1323.0     556.0    EUCTR2020-001363-85-DK   \n",
       " 3532      3532.0    1503.0               NCT04491994   \n",
       " 5244      5244.0    2197.0               NCT04329923   \n",
       " 5245      5245.0    2197.0               NCT04329923   \n",
       " 5246      5246.0    2197.0               NCT04329923   \n",
       " 5247      5247.0    2197.0               NCT04329923   \n",
       " \n",
       "                                          Full text link  \\\n",
       " 546   https://www.clinicaltrialsregister.eu/ctr-sear...   \n",
       " 597         https://clinicaltrials.gov/show/NCT04332991   \n",
       " 662         https://clinicaltrials.gov/show/NCT04343092   \n",
       " 1074        https://ClinicalTrials.gov/show/NCT04345289   \n",
       " 1181        https://clinicaltrials.gov/show/NCT04358081   \n",
       " 1317  https://www.clinicaltrialsregister.eu/ctr-sear...   \n",
       " 1323  https://www.clinicaltrialsregister.eu/ctr-sear...   \n",
       " 3532        https://clinicaltrials.gov/show/NCT04491994   \n",
       " 5244        https://clinicaltrials.gov/show/NCT04329923   \n",
       " 5245        https://clinicaltrials.gov/show/NCT04329923   \n",
       " 5246        https://clinicaltrials.gov/show/NCT04329923   \n",
       " 5247        https://clinicaltrials.gov/show/NCT04329923   \n",
       " \n",
       "                                            First author  \\\n",
       " 546   Medical Information, sanofi-aventis recherche ...   \n",
       " 597                            Boyd Taylor Thompson, MD   \n",
       " 662                              Faiq Gorial, Professor   \n",
       " 1074                                    Thomas Benfield   \n",
       " 1181                           Novartis Pharmaceuticals   \n",
       " 1317                                 Yven Van Herrewege   \n",
       " 1323                         Odense University Hospital   \n",
       " 3532                                Imran m Fazal, FCPS   \n",
       " 5244                                     Ravi Amaravadi   \n",
       " 5245                                     Ravi Amaravadi   \n",
       " 5246                                     Ravi Amaravadi   \n",
       " 5247                                     Ravi Amaravadi   \n",
       " \n",
       "                                                 Contact Registration date  \\\n",
       " 546                    uk-medicalinformation@sanofi.com        30/03/2020   \n",
       " 597   Katie Oldmixon, coldmixon@mgh.harvard.edu (PI ...        31/03/2020   \n",
       " 662                                    faiqig@yahoo.com        05/04/2020   \n",
       " 1074                    thomas.lars.benfield@regionh.dk        14/04/2020   \n",
       " 1181                        novartis.email@novartis.com        08/04/2020   \n",
       " 1317                               yvanherrewege@itg.be        01/04/2020   \n",
       " 1323                                       Not reported        17/04/2020   \n",
       " 3532                                       Not reported        30/07/2020   \n",
       " 5244  Amelia Anderson, amelia.anderson@pennmedicine....        01/04/2020   \n",
       " 5245  Amelia Anderson, amelia.anderson@pennmedicine....        01/04/2020   \n",
       " 5246  Amelia Anderson, amelia.anderson@pennmedicine....        01/04/2020   \n",
       " 5247  Amelia Anderson, amelia.anderson@pennmedicine....        01/04/2020   \n",
       " \n",
       "      Recruitment status Posted results       Publication date  ...  \\\n",
       " 546          Terminated            Yes                     No  ...   \n",
       " 597      Not recruiting            Yes             09/11/2020  ...   \n",
       " 662      Not recruiting            Yes                     No  ...   \n",
       " 1074         Recruiting            Yes                     No  ...   \n",
       " 1181     Not recruiting            Yes                     No  ...   \n",
       " 1317         Terminated            Yes                     No  ...   \n",
       " 1323         Terminated            Yes                     No  ...   \n",
       " 3532          Completed            Yes             04/08/2020  ...   \n",
       " 5244         Terminated            Yes  30/09/2020;26/02/2021  ...   \n",
       " 5245         Terminated            Yes  30/09/2020;26/02/2021  ...   \n",
       " 5246         Terminated            Yes  30/09/2020;26/02/2021  ...   \n",
       " 5247         Terminated            Yes  30/09/2020;26/02/2021  ...   \n",
       " \n",
       "           Treatment name Treatment type Treatment type order  \\\n",
       " 546   Hydroxychloroquine    Antimalaria                 19.0   \n",
       " 597   Hydroxychloroquine    Antimalaria                 19.0   \n",
       " 662   Hydroxychloroquine    Antimalaria                 19.0   \n",
       " 1074  Hydroxychloroquine    Antimalaria                 19.0   \n",
       " 1181  Hydroxychloroquine    Antimalaria                 19.0   \n",
       " 1317  Hydroxychloroquine    Antimalaria                 19.0   \n",
       " 1323  Hydroxychloroquine    Antimalaria                 19.0   \n",
       " 3532  Hydroxychloroquine    Antimalaria                 19.0   \n",
       " 5244  Hydroxychloroquine    Antimalaria                 19.0   \n",
       " 5245  Hydroxychloroquine    Antimalaria                 19.0   \n",
       " 5246  Hydroxychloroquine    Antimalaria                 19.0   \n",
       " 5247  Hydroxychloroquine    Antimalaria                 19.0   \n",
       " \n",
       "       Pharmacological treatment n randomized in this arm Total sample size  \\\n",
       " 546   Pharmacological treatment                      175               350   \n",
       " 597   Pharmacological treatment                      255               510   \n",
       " 662   Pharmacological treatment                       25                50   \n",
       " 1074  Pharmacological treatment                      244              1100   \n",
       " 1181  Pharmacological treatment                      148               444   \n",
       " 1317  Pharmacological treatment                      103               206   \n",
       " 1323  Pharmacological treatment                      103               206   \n",
       " 3532  Pharmacological treatment                      250               500   \n",
       " 5244  Pharmacological treatment                       67               400   \n",
       " 5245  Pharmacological treatment                       67               400   \n",
       " 5246  Pharmacological treatment                       67               400   \n",
       " 5247  Pharmacological treatment                       67               400   \n",
       " \n",
       "                                         primary outcome   Notes  \\\n",
       " 546   1. Phase 2: Change in SpO2/FiO2 ratio from bas...     NaN   \n",
       " 597              COVID Ordinal Outcomes Scale on Day 15     NaN   \n",
       " 662                            Number of cured patients     NaN   \n",
       " 1074  All-cause mortality or need of invasive mechan...     NaN   \n",
       " 1181  Percentage of participants who achieve clinica...     NaN   \n",
       " 1317  Main Objective: To assess if 10 doses of HC, e...     NaN   \n",
       " 1323  Main Objective: To investigate whether prophyl...     NaN   \n",
       " 3532                                        Progression     NaN   \n",
       " 5244  Rate of hospital discharge;Median release from...  Dose 1   \n",
       " 5245  Rate of hospital discharge;Median release from...  Dose 2   \n",
       " 5246  Rate of hospital discharge;Median release from...  Dose 3   \n",
       " 5247  Rate of hospital discharge;Median release from...  Dose 4   \n",
       " \n",
       "                                                  Notes2            Phase  \n",
       " 546                                                 NaN  Phase 2/Phase 3  \n",
       " 597                                                 NaN          Phase 3  \n",
       " 662                                                 NaN          Phase 1  \n",
       " 1074  Results posted in https://www.clinicaltrialsre...          Phase 3  \n",
       " 1181                                                NaN          Phase 3  \n",
       " 1317                                                NaN          Phase 2  \n",
       " 1323                                                NaN          Phase 3  \n",
       " 3532                                                NaN          Phase 3  \n",
       " 5244                        600mg once a day (2 months)          Phase 2  \n",
       " 5245                        400mg twice a day (14 days)          Phase 2  \n",
       " 5246                          600mg once a day (7 days)          Phase 2  \n",
       " 5247                        600mg twice a day (14 days)          Phase 2  \n",
       " \n",
       " [12 rows x 33 columns],\n",
       " Empty DataFrame\n",
       " Columns: [Unnamed: 0, Trial ID, Trial registration number, Full text link, First author, Contact, Registration date, Recruitment status, Posted results, Publication date, Study design, Allocation, Design, Masking, Center, Study aim, Number of arms, Funding, Inclusion age min, Inclusion age max, Countries, Type of patients, Severity scale, Treatment name, Treatment type, Treatment type order, Pharmacological treatment, n randomized in this arm, Total sample size, primary outcome, Notes, Notes2, Phase]\n",
       " Index: []\n",
       " \n",
       " [0 rows x 33 columns])"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "trials = df[(df['Treatment name'] == 'Hydroxychloroquine')&(df['Posted results'] == 'Yes')]\n",
    "trials_2= df[(df['Treatment name'] == 'Azithromycin')&(df['Posted results'] == 'Yes')]\n",
    "\n",
    "trials,trials_2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "backed-clear",
   "metadata": {},
   "outputs": [],
   "source": [
    "trials_list = trials.values.tolist()\n",
    "links = []"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "continent-logic",
   "metadata": {},
   "outputs": [],
   "source": [
    "for i in range(len(trials_list)):\n",
    "    trial_id_1, name_1, type_1, link = trials_list[i][0], trials_list[i][1], trials_list[i][2], trials_list[i][3]\n",
    "    if link not in links :\n",
    "        links.append(link)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "opponent-baptist",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['https://clinicaltrials.gov/show/NCT04292899',\n",
       " 'https://clinicaltrials.gov/show/NCT04292730',\n",
       " 'https://clinicaltrials.gov/show/NCT04280705',\n",
       " 'https://jrct.niph.go.jp/latest-detail/jRCTs041190120',\n",
       " 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001243-15',\n",
       " 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001270-29',\n",
       " 'https://clinicaltrials.gov/show/NCT04332991',\n",
       " 'https://clinicaltrials.gov/show/NCT04343092',\n",
       " 'https://ClinicalTrials.gov/show/NCT04345289',\n",
       " 'https://clinicaltrials.gov/show/NCT04358081',\n",
       " 'https://clinicaltrials.gov/show/NCT04358068',\n",
       " 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001417-21',\n",
       " 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001363-85',\n",
       " 'https://clinicaltrials.gov/show/NCT04390022',\n",
       " 'https://clinicaltrials.gov/show/NCT04410159',\n",
       " 'https://clinicaltrials.gov/show/NCT04422561',\n",
       " 'https://clinicaltrials.gov/show/NCT04446429',\n",
       " 'https://clinicaltrials.gov/show/NCT04491240',\n",
       " 'https://clinicaltrials.gov/show/NCT04491994',\n",
       " 'https://clinicaltrials.gov/show/NCT04523831',\n",
       " 'https://clinicaltrials.gov/show/NCT04542694',\n",
       " 'https://clinicaltrials.gov/show/NCT04329923',\n",
       " 'https://clinicaltrials.gov/show/NCT04646109']"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "links"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "comfortable-holocaust",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
